Literature DB >> 19016749

Subclassification of non-solid-type papillary thyroid carcinoma identification of high-risk group in common type.

Yanhua Bai1, Kennichi Kakudo, Yaqiong Li, Zhiyan Liu, Takashi Ozaki, Yasuhiro Ito, Minoru Kihara, Akira Miyauchi.   

Abstract

Two hundred and sixty-three cases of primary human papillary thyroid carcinoma (PTC) were analyzed. All cases met the following parameters: tumor size > or = 10 mm, no distant metastasis at presentation, and no coexistence of other histological type. The histological features of the solid/trabecular component, encapsulation, tall/columnar cell component and loss of polarity/cohesiveness were utilized to subclassify the 263 cases of PTC into five groups: solid type (15.6%), encapsulated group (9.5%), tall/columnar cell group (7.2%), micropapillary/discohesive group (19.8%) and not-otherwise-specified group (47.9%). We focused on the latter four non-solid groups and compared their prognosis with the solid type. The tall/columnar cell group showed the worst disease-free survival rate (DFS) analyzed by the Kaplan-Meier method, followed by the micropapillary/discohesive group. The not-otherwise-specified group and encapsulated group showed a better DFS rate than the solid type. Cancer-related death was noted in the tall/columnar cell group (21.1%) and micropapillary/discohesive group (3.8%), but not in the other groups. The four non-solid histological groups were further categorized into two prognostic groups: high-risk group (including tall/columnar cell group and micropapillary/discohesive group); and low-risk group (including encapsulated group and not-otherwise-specified group). Their 10-year disease-free survival rates were 78.7% and 93.1%, respectively. In the present study, histological grouping was significantly correlated with prognosis in the multivariate analysis according to the Cox proportional hazards regression model in addition to clinical parameters of extrathyroid invasion and gross lymph node metastasis, which predicts the patient outcome in terms of tumor recurrence and cancer-related death more precisely.

Entities:  

Mesh:

Year:  2008        PMID: 19016749     DOI: 10.1111/j.1349-7006.2008.00908.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  18 in total

1.  Encapsulated papillary thyroid carcinoma: is it a distinctive clinical entity with low-grade malignancy?

Authors:  A Pisanu; D Deplano; I Reccia; G Porceddu; A Uccheddu
Journal:  J Endocrinol Invest       Date:  2012-01-31       Impact factor: 4.256

2.  In papillary thyroid carcinoma, expression by immunohistochemistry of BRAF V600E, PD-L1, and PD-1 is closely related.

Authors:  Yanhua Bai; Ting Guo; Xiaozheng Huang; Qi Wu; Dongfeng Niu; Xinqiang Ji; Qin Feng; Zhongwu Li; Kennichi Kakudo
Journal:  Virchows Arch       Date:  2018-04-12       Impact factor: 4.064

3.  Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile.

Authors:  Carrie C Lubitz; Konstantinos P Economopoulos; Amanda C Pawlak; Kerry Lynch; Dora Dias-Santagata; William C Faquin; Peter M Sadow
Journal:  Thyroid       Date:  2014-03-06       Impact factor: 6.568

Review 4.  How to handle borderline/precursor thyroid tumors in management of patients with thyroid nodules.

Authors:  Kennichi Kakudo
Journal:  Gland Surg       Date:  2018-08

Review 5.  Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.

Authors:  Paula Soares; Antónia Afonso Póvoa; Miguel Melo; João Vinagre; Valdemar Máximo; Catarina Eloy; José Manuel Cameselle-Teijeiro; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2021-03-02       Impact factor: 3.943

6.  The effect of implementing pre-surgical ultrasound-guided fine-needle aspiration biopsy on thyroid surgery, a 6-year interrupted time series analysis in Qilu Hospital of Shandong University.

Authors:  Zhiyan Liu; Shaofeng Sui; Peng Su; Xiaofang Zhang; Jing Hu; Feifei Sun; Bo Han
Journal:  Gland Surg       Date:  2020-10

7.  Prognostic values of thyroid tumours.

Authors:  Suzana Manxhuka-Kerliu; Emine Devolli-Disha; Arsim Gerxhaliu; Halil Ahmetaj; Arijeta Baruti; Sadushe Loxha; Hajdin Thaqi
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

Review 8.  Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.

Authors:  Jinwei Hu; Isabella J Yuan; Saied Mirshahidi; Alfred Simental; Steve C Lee; Xiangpeng Yuan
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

9.  Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population.

Authors:  Hye Sook Min; Chul Lee; Kyeong Cheon Jung
Journal:  J Korean Med Sci       Date:  2013-03-27       Impact factor: 2.153

10.  Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study.

Authors:  Mijin Kim; Sun Wook Cho; Young Joo Park; Hwa Young Ahn; Hee Sung Kim; Yong Joon Suh; Dughyun Choi; Bu Kyung Kim; Go Eun Yang; Il-Seok Park; Ka Hee Yi; Chan Kwon Jung; Bo Hyun Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.